DynamiCare Health
6 Liberty Square, Suite 2102, Boston, MA, 02109, United States
Overview
DynamiCare Health offers an evidence-based digital platform to reinforce recovery from addiction through smartphone-delivered breath and saliva tests, GPS-verified treatment attendance check-ins, telehealth recovery coaching, and rewards deposited on a smart debit card that blocks cash withdrawals and spending at bars and liquor stores. The company says three published clinical trials validate its effectiveness, showing 2–3x improvements in quit rates across drugs, alcohol, and tobacco. Its digital care program is already being used by major health plans, health systems, and research universities. DynamiCare was founded in 2016 by Eric Gastfriend and David R. Gastfriend. The company raised an additional $1.5M in seed funding, bringing total equity funding to $5.6M, and has won over $3M in awards and grants, including three NIH grants. It plans to use the new funds to roll out its program across health plans, employers, government agencies, and the direct-to-consumer market. DynamiCare Health, founded in 2016 and based in Boston, offers an evidence-based digital platform to support addiction recovery. Its core product is a behavioral intervention app that automates Contingency Management by delivering random breath and saliva tests via phone, GPS-verified treatment attendance check-ins, and supportive telehealth recovery coaching. The platform issues rewards for healthy progress via deposits onto a smart debit card that blocks cash withdrawals and spending at bars and liquor stores. The company planned to roll the app directly to consumers later this spring and to advance its telehealth recovery coaching service. DynamiCare’s incentive-driven approach is grounded in research—Contingency Management has been shown effective in over 100 randomized controlled trials—and the technology was already being used at seven addiction treatment programs across the country. Founders are Eric Gastfriend, a Harvard MBA tech executive, and his father David R. Gastfriend, MD, an international expert in addiction psychiatry. The company raised seed funding to support these product rollouts and service expansion.
- Total raised
- $6M
- Funding rounds
- 2
- Latest round
- Seed
- Latest activity
- Jul 2021
Industries
- Health Care
- Information Technology
- Medical
- Therapeutics
Recent funding
Seed
Jul 2021
$2M
Seed
Apr 2019
$4M